Does SAXAGLIPTIN Cause Interstitial lung disease? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Interstitial lung disease have been filed in association with SAXAGLIPTIN (SAXAGLIPTIN). This represents 0.5% of all adverse event reports for SAXAGLIPTIN.
12
Reports of Interstitial lung disease with SAXAGLIPTIN
0.5%
of all SAXAGLIPTIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From SAXAGLIPTIN?
Of the 12 reports, 3 (25.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SAXAGLIPTIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does SAXAGLIPTIN Cause?
Cardiac failure congestive (393)
Cardiac failure (360)
Cardiovascular disorder (159)
Blood glucose increased (152)
Weight decreased (124)
Death (115)
Nausea (113)
Drug ineffective (105)
Dizziness (91)
Drug dose omission (89)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SAXAGLIPTIN Alternatives Have Lower Interstitial lung disease Risk?
SAXAGLIPTIN vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SAXAGLIPTIN vs SCOPOLAMINE
SAXAGLIPTIN vs SCOPOLAMINE HYDROBROMIDE
SAXAGLIPTIN vs SEBELIPASE ALFA
SAXAGLIPTIN vs SECNIDAZOLE